Showing results (811-820 of 1,043) with videos related to
Sort By:
Pageof 105
JAMA Network Open|May 23, 2020
Evaluation of Domains of Patient-Reported Outcome Measures for Recovery After Childbirth: A Scoping and Systematic ReviewPervez Sultan, Nishant Sadana, Nadir Sharawi, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Association of itch triggers with atopic dermatitis severity and course in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.Journal of the American Academy of Dermatology|May 20, 2020
Association of atopic dermatitis severity with cognitive function in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.Patient Preference and Adherence|April 21, 2020
Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)Karen Kaiser, Susan E Yount, Christa E Martens, et al.Pain|October 17, 2007
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with painDennis C Turk, Robert H Dworkin, Dennis Revicki, et al.Neurorehabilitation and Neural Repair|July 27, 2011
Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOLJin-Shei Lai, Cindy Nowinski, David Victorson, et al.Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.Current Opinion in Supportive and Palliative Care|January 29, 2026
Comparison of the EORTC QLQ PR25 and the FACT-P for assessing quality of life in patients with prostate cancer - an updated literature reviewDavid Chen, Jane Jomy, Tony Ning, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS StudyElizabeth A Hahn, G Alastair Glendenning, Mark V Sorensen, et al.Journal of the National Cancer Institute|September 20, 2013
Recommendations for high-priority research on cancer-related fatigue in children and adultsAndrea M Barsevick, Michael R Irwin, Pamela Hinds, et al.Pageof 105